161 related articles for article (PubMed ID: 12650607)
21. Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt-1) expression in endothelial cells.
Funasaka T; Haga A; Raz A; Nagase H
Int J Cancer; 2002 Sep; 101(3):217-23. PubMed ID: 12209971
[TBL] [Abstract][Full Text] [Related]
22. Aberrant expression of the autocrine motility factor receptor correlates with poor prognosis and promotes metastasis in gastric carcinoma.
Huang Z; Zhang N; Zha L; Mao HC; Chen X; Xiang JF; Zhang H; Wang ZW
Asian Pac J Cancer Prev; 2014; 15(2):989-97. PubMed ID: 24568530
[TBL] [Abstract][Full Text] [Related]
23. Autocrine motility factor receptor as a possible urine marker for transitional cell carcinoma of the bladder.
Korman HJ; Peabody JO; Cerny JC; Farah RN; Yao J; Raz A
J Urol; 1996 Jan; 155(1):347-9. PubMed ID: 7490884
[TBL] [Abstract][Full Text] [Related]
24. Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells.
Nam SW; Clair T; Campo CK; Lee HY; Liotta LA; Stracke ML
Oncogene; 2000 Jan; 19(2):241-7. PubMed ID: 10645002
[TBL] [Abstract][Full Text] [Related]
25. Autocrine motility factor receptor promotes the malignancy of glioblastoma by regulating cell migration and invasion.
Zhang Y; Wang X; Chen G; Lu Y; Chen Q
Neurol Res; 2024 Jan; 46(1):89-97. PubMed ID: 37703903
[TBL] [Abstract][Full Text] [Related]
26. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor.
Taniguchi K; Yonemura Y; Nojima N; Hirono Y; Fushida S; Fujimura T; Miwa K; Endo Y; Yamamoto H; Watanabe H
Cancer; 1998 Jun; 82(11):2112-22. PubMed ID: 9610690
[TBL] [Abstract][Full Text] [Related]
27. AMF/G6PI induces differentiation of leukemic cells via an unknown receptor that differs from gp78.
Haga A; Komazaki S; Funasaka T; Hashimoto K; Yokoyama Y; Watanabe H; Raz A; Nagase H
Leuk Lymphoma; 2006 Oct; 47(10):2234-43. PubMed ID: 17071500
[TBL] [Abstract][Full Text] [Related]
28. Effect of farnesyltransferase overexpression on cell growth and transformation.
Nagase T; Kawata S; Nakajima H; Tamura S; Yamasaki E; Fukui K; Yamamoto K; Miyagawa J; Matsumura I; Matsuda Y; Matsuzawa Y
Int J Cancer; 1999 Jan; 80(1):126-33. PubMed ID: 9935242
[TBL] [Abstract][Full Text] [Related]
29. [The role of autocrine motility factor receptor in metastasis].
Watanabe H; Chigira M; Raz A
Gan To Kagaku Ryoho; 1993 Feb; 20(3):405-9. PubMed ID: 8382466
[TBL] [Abstract][Full Text] [Related]
30. Tumor cell autocrine motility factor receptor.
Nabi IR; Watanabe H; Silletti S; Raz A
EXS; 1991; 59():163-77. PubMed ID: 1655517
[TBL] [Abstract][Full Text] [Related]
31. Autocrine motility factor and its receptor expression in musculoskeletal tumors.
Nakajima K; Raz A
J Bone Oncol; 2020 Oct; 24():100318. PubMed ID: 33101887
[TBL] [Abstract][Full Text] [Related]
32. Transformation of an established mouse mammary epithelial cell line following transfection with a human transforming growth factor alpha cDNA.
Shankar V; Ciardiello F; Kim N; Derynck R; Liscia DS; Merlo G; Langton BC; Sheer D; Callahan R; Bassin RH
Mol Carcinog; 1989; 2(1):1-11. PubMed ID: 2786419
[TBL] [Abstract][Full Text] [Related]
33. Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells.
Silletti S; Yao JP; Pienta KJ; Raz A
Int J Cancer; 1995 Sep; 63(1):100-5. PubMed ID: 7558435
[TBL] [Abstract][Full Text] [Related]
34. Autocrine motility factor and its receptor: role in cell locomotion and metastasis.
Nabi IR; Watanabe H; Raz A
Cancer Metastasis Rev; 1992 Mar; 11(1):5-20. PubMed ID: 1324804
[TBL] [Abstract][Full Text] [Related]
35. The interferon-inducible gene, Ifi204, acquires malignant transformation capability upon mutation at the Rb-binding sites.
De Andrea M; Ravotto M; Noris E; Ying GG; Gioia D; Azzimonti B; Gariglio M; Landolfo S
FEBS Lett; 2002 Mar; 515(1-3):51-7. PubMed ID: 11943193
[TBL] [Abstract][Full Text] [Related]
36. Giant cell tumors of the bone: molecular profiling and expression analysis of Ephrin A1 receptor, Claudin 7, CD52, FGFR3 and AMFR.
Guenther R; Krenn V; Morawietz L; Dankof A; Melcher I; Schaser KD; Kasper HU; Kuban RJ; Ungethüm U; Sers C
Pathol Res Pract; 2005; 201(10):649-63. PubMed ID: 16325507
[TBL] [Abstract][Full Text] [Related]
37. The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum.
Fang S; Ferrone M; Yang C; Jensen JP; Tiwari S; Weissman AM
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14422-7. PubMed ID: 11724934
[TBL] [Abstract][Full Text] [Related]
38. Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells.
Zhang L; Kharbanda S; Hanfelt J; Kern FG
Cancer Res; 1998 Jan; 58(2):352-61. PubMed ID: 9443417
[TBL] [Abstract][Full Text] [Related]
39. N-myc oncogene enhances mitogenic responsiveness of diploid human fibroblasts to growth factors but fails to immortalize.
Brondyk WH; Boeckman FA; Fahl WE
Oncogene; 1991 Jul; 6(7):1269-76. PubMed ID: 1861869
[TBL] [Abstract][Full Text] [Related]
40. Expression of autocrine motility factor receptor in serum- and protein-independent fibrosarcoma cells: implications for autonomy in tumor-cell motility and metastasis.
Watanabe H; Shinozaki T; Raz A; Chigira M
Int J Cancer; 1993 Feb; 53(4):689-95. PubMed ID: 8382196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
